Sam Yuen

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

Kerry J. Savage, Steven M. Horwitz, Ranjana H. Advani et al. · Blood Advances · 2022 · 40 citations · Full text

Medicine, Oncology, Chemotherapy +11

Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Updated Analysis of a Phase I/II Study

Anas Younes, John M. Burke, Bruce D. Cheson et al. · Blood · 2019 · 25 citations

Medicine, Oncology, Pharmacotherapy +13

Americans of East Asian Ancestry: Aging and the Aged

Rachel Kalish, Sam Yuen · The Gerontologist · 1971 · 21 citations

Education, Geriatric Medicine, Aging +10

Polatuzumab Vedotin Plus Venetoclax with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Primary Efficacy Analysis of a Phase Ib/II Study

Giuseppe Gritti, Paula Marlton, Tycel Phillips et al. · Blood · 2020 · 20 citations

Life Sciences, Immunology, Pharmacotherapy +12

Zanubrutinib plus obinutuzumab (ZO) versus obinutuzumab (O) monotherapy in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): Primary analysis of the phase 2 randomized ROSEWOOD trial.

Pier Luigi Zinzani, Jiří Mayer, Rebecca Auer et al. · Journal of Clinical Oncology · 2022 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +16